CI
BIIB icon

Cavalier Investments’s Biogen BIIB Stock Holding History

Cavalier Investments’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-4,708
Closed -$1.26M – 70
2020
Q2 		$1.26M Buy
+4,708
New +$1.42M 0.73% 46
2017
Q2 		– Sell
-735
Closed -$201K – 147
2017
Q1 		$201K Sell
735
-60
-8% -$17K 0.11% 143
2016
Q4 		$225K Buy
795
+25
+3% +$7.41K 0.14% 107
2016
Q3 		$241K Buy
+770
New +$228K 0.15% 105
2016
Q1 		– Sell
-3,100
Closed -$950K – 104
2015
Q4 		$950K Buy
+3,100
New +$891K 0.56% 31

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Cavalier Investments's BIIB Position: Q3 2020 in Review

Cavalier Investments sold out of Biogen (BIIB) in Q3 2020, closing a stake of 4,708 shares — an estimated $1.26M sold.

Cavalier Investments first reported a position in BIIB in Q4 2015 and held it in 5 quarters. The position peaked at $1.26M in Q2 2020. 1,051 funds tracked by Wall St. Rank hold BIIB as of Q3 2020.

  • Cavalier Investments reported no remaining Biogen position as of Q3 2020 after selling out during the quarter.
  • Cavalier Investments sold 4,708 Biogen shares in Q3 2020, an estimated $1.26M.
  • Cavalier Investments first reported a position in Biogen in Q4 2015 and held it in 5 quarters.
  • Cavalier Investments's Biogen position peaked at $1.26M in Q2 2020.
  • 1,051 funds tracked by Wall St. Rank held Biogen as of Q3 2020.

Based on Cavalier Investments's 13F filing for Q3 2020, filed 12 Nov 2020.